Guidance
Recommendations for research
Recommendations for research
The guideline committee has made the following recommendations for research.
Key recommendations for research
1 Anticholinergic medicines
What is the effectiveness and safety of anticholinergic medicines for overactive bladder in older women? [2019]
For a short explanation of why the committee made the recommendation for research, see the rationale on medicines for overactive bladder.
Full details of the evidence and the committee's discussion are in evidence review C: the risks to cognitive function for women taking anticholinergic drugs for overactive bladder.
2 Colpocleisis compared with sacrospinous fixation for pelvic organ prolapse
What is the effectiveness of colpocleisis compared with sacrospinous fixation for pelvic organ prolapse in elderly women? [2019]
For a short explanation of why the committee made the recommendation for research, see the rationale on surgical management of pelvic organ prolapse.
Full details of the evidence and the committee's discussion are in evidence review I: surgical management of pelvic organ prolapse.
3 Assessing complications associated with mesh surgery
What is the effectiveness of ultrasound-guided visualisation compared with clinical assessment to identify complications after mesh surgery for stress urinary incontinence or pelvic organ prolapse in women? [2019]
For a short explanation of why the committee made the recommendation for research, see the rationale on assessing complications associated with mesh surgery.
Full details of the evidence and the committee's discussion are in evidence review K: assessing mesh complications after pelvic floor mesh surgery.
4 Pessaries or surgery for pelvic organ prolapse
What are the long-term outcomes, including patient satisfaction, from the use of pessaries compared with surgery for pelvic organ prolapse in women? [2019]
For a short explanation of why the committee made the recommendation for research, see the rationale on non-surgical management of pelvic organ prolapse.
Full details of the evidence and the committee's discussion are in evidence review H: lifestyle and conservative management options for pelvic organ prolapse.
5 Long-term risks of surgery with and without mesh
What are the long-term risks of mesh surgery compared with non-mesh surgery for stress urinary incontinence and pelvic organ prolapse in women? [2019]
For a short explanation of why the committee made the recommendation for research, see the rationale on surgical management of stress urinary incontinence and surgical management of pelvic organ prolapse.
Full details of the evidence and the committee's discussion are in:
Other recommendations for research
Long-term effectiveness of botulinum toxin type A for overactive bladder
What is the long-term effectiveness of bladder wall injection with botulinum toxin type A for overactive bladder in women? [2019]
For a short explanation of why the committee made the recommendation for research, see the rationale on botulinum toxin type A injection.
Full details of the evidence and the committee's discussion are in evidence review D: management of overactive bladder.
Surgery for stress urinary incontinence and pelvic organ prolapse
What is the most effective surgical management for women with both stress urinary incontinence and pelvic organ prolapse, including the sequence of interventions? [2019]
For a short explanation of why the committee made the recommendation for research, see the rationale on surgery for women with both stress urinary incontinence and pelvic organ prolapse.
Full details of the evidence and the committee's discussion are in evidence review J: surgical management of pelvic organ prolapse and stress urinary incontinence.
Pain management after mesh surgery
What is the effectiveness of pain management for women who present with chronic pain 3 months after mesh surgery for stress urinary incontinence or pelvic organ prolapse? [2019]
For a short explanation of why the committee made the recommendation for research, see the rationale on managing complications associated with mesh surgery.
Full details of the evidence and the committee's discussion are in evidence review L: management of mesh complications.